Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis.

Karthik R CherukupallyKodjovi KodjoOluwaseun OgunsakinOlaniyi O OlayinkaPatrice Fouron

Published in: Case reports in psychiatry (2020)

Depressive and anxiety symptoms usually develop as comorbidity during MG disease. Depressive and anxiety symptoms, besides motor symptoms, have a negative impact on the quality of life. Mental health must be a clinical focus during the treatment of somatic symptoms during MG.

Keyphrases

sleep quality
mental health
bipolar disorder
myasthenia gravis
gene expression
depressive symptoms
dna methylation
case report
copy number